The role of 18F-FDG PET/CT in detecting colorectal cancer recurrence in patients with elevated CEA levels

Nuclear Medicine Communications

Volumn 33, Issue 4, 2012, Pages 395-402

  Ozkan, Elgin ^a   Soydal, Cigdem ^b   Araz, Mine ^b   Kir, Kemal Metin ^b   Ibis, Erkan ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18; TUMOR MARKER; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURGERY; CLINICAL EVALUATION; COLORECTAL CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); CONTRAST ENHANCED COMPUTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG UPTAKE; FEMALE; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; SENSITIVITY AND SPECIFICITY; WHOLE BODY PET; AGED; BLOOD; COLORECTAL TUMOR; COMPARATIVE STUDY; METHODOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY; SCINTISCANNING; TUMOR RECURRENCE; WHOLE BODY IMAGING;

AGED; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 84858219397     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32834f7dbe     Document Type: Article

References (18)

1. Sarikaya I, Bloomston M, Povoski SP, Zhang J, Hall NC, Knopp MV, et al. FDG-PET scan in patients with clinically and/or radiologically suspicious colorectal cancer recurrence but normal CEA. World J Surg Oncol 2007; 5:64-72.
2. Hine KR, Dykes PW, Serum CEA. Testing in the post-operative surveillance of colorectal carcinoma. Br J Cancer 1984; 49:689-693. (Pubitemid 14113724)
3. Galandiuk S, Wieand HS, Moertel CG, Cha SS, Fitzgibbons RJ Jr, Pemberton JH, et al. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 1992; 174:27-32.
4. Martin EW Jr, Cooperman M, Carey LC, Minton JP. Sixty second-look procedures indicated primarily by rise in serial carcinoembryonic antigen. J Surg Res 1980; 28:389-394. (Pubitemid 10116914)
5. McCall JL, Black RB, Rich CA, Harvey JR, Baker RA, Watts JM, et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum 1994; 37:875-881. (Pubitemid 24281920)
6. Flamen P, Hoekstra OS, Homans F, Van Cutsem E, Maes A, Stroobants S, et al. Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET). Eur J Cancer 2001; 37:862-869. (Pubitemid 32323964)
7. Metser U, You J, McSweeney S, Freeman M, Hendler A. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen. AJR Am J Roentgenol 2010; 194:766-771.
8. Chen LB, Tong JL, Song HZ, Zhu H, Wang YC. (18)F-DG PET/CT in detection of recurrence and metastasis of colorectal cancer. World J Gastroenterol 2007; 13:5025-5029. (Pubitemid 47496838)
9. Kyoto Y, Momose M, Kondo C, Itabashi M, Kameoka S, Kusakabe K. Ability of 18F-FDG PET/CT to diagnose recurrent colorectal cancer in patients with elevated CEA concentrations. Ann Nucl Med 2010; 24: 395-401.
10. Lee JH, Park SG, Jee KN, Park DG, Namgung H, Song IH. Performance of FDG PET/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level. Nucl Med Commun 2010; 31:576-582.
11. Cass AW, Million RR, Pfaff WW. Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum. Cancer 1976; 37: 2861-2865.
12. Olson RM, Perencevich NP, Malcolm AW, Chaffey JT,Wilson RE. Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum. Cancer 1980; 45:2969-2974. (Pubitemid 11191741)
13. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA 1993; 270:943-947. (Pubitemid 23244732)
14. Huebner RH, Park KC, Shepherd JE, Schwimmer J, Czernin J, Phelps ME, et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 2000; 41:1177-1189. (Pubitemid 30464000)
15. Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh B, Kapoor R, et al. 18F-FDG PET-CT in evaluation of postoperative colorectal cancer patients with rising CEA level. Nucl Med Commun 2011; 32:789-793.
16. Ruibal Morell A. CEA serum levels in non-neoplastic disease. Int J Biol Markers 1992; 7:160-166.
17. Chevinsky AH. CEA in tumors of other than colorectal origin. Semin Surg Oncol 1991; 7:162-166.
18. Morton KA, Clark PB. Diagnostic imaging nuclear medicine. 1st ed. Section 8 Utah: Amirsys; 2007. pp. 56-57.